The in vivo formation of covalent aflatoxin B1
tives. The alkali-treated DNA was hybridized to 18S and 28S rRNA in 70% formamide buffer to form rRNA-rDNA hybrids. These hybrids were separated from the bulk of nuclear DNA by two rounds of centrifugation in CsCI, and the level of AFB1 adduction to rDNA versus total nuclear DNA was compared as a function of dose 2 hr after AFB, administration. Over an 8- fold dose range (0.25-2.0 mg of AFB1 per kg of body weight), rDNA contained 4-to 5-fold more AFB1 residues than nuclear DNA, indicating that rDNA is preferentially accessible to carcinogen modification in vivo. While aflatoxin B1 forms adducts with DNA principally at guanine residues, the guanine enrichment of rDNA was insufficient to explain the magnitude of observed preferential AFB, modification of rDNA. These results support the hypothesis that rDNA regions are preferentially accessible to carcinogen modification because of the diffuse conformation maintained within transcribed genes. This experimental approach permits the quantitative description of carcinogen modification within a defined gene sequence; further refinement of this approach may be useful in defining the precise relationships between covalent chemical-DNA interactions and the alterations in gene expression that result.
The irreversibility of tumor initiation, as well as the heritability of the tumor phenotype, have drawn attention to DNA as the critical macromolecular target in chemical carcinogenesis (1, 2) . Changes in DNA sequences, brought about by carcinogen-DNA interactions, could constitute molecular bases for observed alterations in gene expression that accompany neoplastic transformation by chemicals (3, 4) . Evidence supporting a putative role of carcinogen-induced DNA sequence change in initiating tumor development has been provided by both qualitative and quantitative correlations between the carcinogenic and mutagenic potency exhibited by many carcinogens and the potency of chemicals as carcinogens compared to the total levels of covalent DNA modification observed in treated animals (5) (6) (7) (8) (9) .
Elucidation of the molecular bases for mutation and tumor initiation by carcinogens will require detailed knowledge of DNA modification within specific base sequences that can be related to alterations in gene function. Earlier experiments with this objective have included attempts to relate mutation frequency with DNA adduct formation by mutagens/carcinogens such as benzo[a]pyrene (10) and aflatoxin B1 (AFB1) (11, 12) . While this approach has provided quantitative data on apparent mutagenic efficiency of various DNA adducts, structural modifications could not be localized within the marker genes in which mutation was scored. Furthermore, this quantitative approach assumes that DNAcarcinogen adducts are randomly distributed. Recent studies have indicated the susceptibility to carcinogen modification is not random but is affected by factors such as transcriptional activity, specific neighboring base composition, and nucleotide sequence (13) .
We have conducted experiments to investigate the structural and functional impairment of a specific gene sequence, the rRNA gene, by the hepatocarcinogen AFB1. Our experimental design permits simultaneous investigation of chemical damage and repair within an expressed gene as well as the resulting functional impairment in those same gene sequences. AFB1 was used in these studies because products of its reaction with DNA have been thoroughly characterized, and the only known site of reaction is at the N7 position of guanine (14) (15) (16) . Furthermore, extensive information about AFB1-DNA adduct stability and removal has facilitated development of hybridization technology permitting isolation of AFB1-adducted gene sequences and quantitation of aflatoxin residues within them.
rDNA, the DNA sequences coding for the 45S precursor to 18S and 28S rRNA, was investigated for two reasons. First, these genes are present in approximately 300 copies per cell in the rat, and the presence of multiple copies makes it feasible to isolate sufficient rDNA for quantitative adduct analysis. Second, rRNA synthesis is preferentially inhibited (as compared to the synthesis of mRNA and tRNA) in AFB1-treated animals, exclusively to the impairment of rDNA template function (17) . These biochemical findings suggest that the rRNA genes are preferential targets for AFB1 modification and thus appropriate model gene sequences with which to study localized carcinogen modification.
In this report, we describe the isolation of rDNA from the liver of AFB1-treated animals and the determination of levels of adduction within rDNA as well as in total nuclear DNA after single doses of AFB1 (0.25-2.0 mg/kg). The results indicate that rDNA, a region of actively transcribed sequences within the nuclear genome, is preferentially susceptible to carcinogen modification in vivo.
MATERIALS AND METHODS
The experimental strategy employed for rDNA isolation is summarized in Fig. 1 (18) with all procedures being performed at 0-40C. Nucleic acids were isolated from the resultant crude nuclear preparation by phenol extraction essentially as described by Marmur (19) . The nuclear DNA isolate was resuspended in H buffer (50 mM Hepes, pH 7.0/5 mM Na2EDTA) at a 0.5 mg/ml and sheared by 15 strokes in a Teflon-glass homogenizer. Sodium sarcosinate was added to 1%, and the mixture was again homogenized. To each vol of homogenized nuclei, 7 vol of 6 M CsCl, 0.8 vol of 3 M Cs2SO4, and 0.25 vol of H buffer were added. The samples were transferred to Beckman 38-ml quick-seal tubes, overlayed with mineral oil, and centrifuged at 167,000 x g in a Beckman VTi 50 rotor for 10.5-12.5 hr at 20'C. Each cesium gradient was fractionated while monitoring absorbance at 254 nm, and the DNA fractions of greatest cesium salt density (accounting for approximately 10% of the total DNA loaded onto each gradient) were retained. Nuclear DNA fractions enriched in rDNA as described above were briefly dialyzed, precipitated with ethanol, and solubilized in 0.11 M glycine/NaOH, pH 10.5, at a DNA concentration of 0.7-0.9 mg/ml. After incubation for 30 min at 370C, the solution was made 0.3 M in NaCl, and the DNA was recovered by ethanol precipitation. Samples of the DNA fraction were taken before and after glycine treatment to determine the loss of aflatoxin-bound radioactivity (due mainly to tritium exchange) during base treatment. AFB1-bound tritium was determined by liquid scintillation counting, and DNA was quantified by the diphenylamine colorimetric reaction as modified by Giles and Myers (20) . rDNA sequences were isolated from nuclear DNA via hybridization with rRNA according to procedures adapted from the methods of Wellauer and Dawid (21, 22) . The alkalitreated nuclear DNA pellet was washed twice with -70'C ethanol/0.3 M NaCl (9:1, vol/vol) and dissolved in formamide hybridization buffer [70% formamide (vol/vol)/0.3 M NaCl/10 mM Tris HCl, pH 7.2/1 mM Na2EDTA] at a DNA concentration of 15 Ag/ml. The 18S and 28S rRNA hybridization probes were prepared by layering total liver RNA onto 10-40% detergent sucrose gradients and chromatographing the 18S and 28S peaks on an oligo(dT)-cellulose column as described by Aviv and Leder (23) . Purified 18S and 28S rRNA were added to the nuclear DNA solution at a final concentration of 15 ,ug/ml for each RNA species. The nucleic acid mixture was transferred to ampoules, incubated at 50'C for 3 hr, cooled to 40C, and finally dialyzed against TE buffer (10 mM Tris-HCl, pH 7.2/2.5 mM Na2EDTA). Cesium chloride was added to a density of 1.71 g/ml, and the DNA-rRNA mixture was centrifuged as described above. DNA peak fractions of maximum density, comprising approximately 20-25% of the DNA band, were readjusted to a density of 1.72 g/ml with CsCl and recentrifuged. The rDNA-rRNA hybrids were located on the gradient by filter hybridization to 32P end-labeled 18S and 28S rRNA as described by Mertz and Gurdon (24) .
The rDNA hybrid fractions were pooled, dialyzed against TE buffer, and digested for 30 min at 440C with heat-treated RNase A (Sigma) added to give 20 ,ug/ml. The RNase digest was extracted with an equal volume of phenol, and the rDNA was recovered from the aqueous layer by ethanol precipitation. The purity of rDNA isolates was tested by digesting samples with EcoRI restriction endonuclease (Bethesda Research Laboratories), electrophoretically separating the digest on a 1% agarose gel stained with ethidium bromide. The gel contents were also transferred to a nitrocellulose filter and hybridized with [32P]rRNA according to the Southern method (25) .
RESULTS
Isolation of AFB1-Adducted rDNA. Employing these procedures, we have purified a rDNA from the liver nuclear DNA of animals administered single doses of AFB1. Total nuclear DNA was sheared and banded in cesium chloride/ cesium sulfate density gradients, which served two purposes: DNA purification via removal of RNA and protein and enrichment of rRNA genes, which have a higher guanine and cytosine content than does nuclear DNA and therefore band at a higher density on cesium salt gradients. Consistent with previous reports, rDNA sequences were found to band in the lower (greater density) side of the nuclear DNA peak. A fraction enriched in rRNA gene sequences and suitable for hybridization to rRNA could thus be selectively separated from nuclear DNA.
Adduct Stabilization. The predominant adduct formed initially in DNA modified by AFB1 either in vitro or in vivo is 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 (AFB1-N7-guanine) (14) (15) (16) . This adduct is chemically unstable, a characteristic shared by all N7-modified guanines, and readily undergoes spontaneous depurination. To enable quantification of AFB1 adduction to rDNA, it was necessary to convert AFB1-N7-guanine adducts to a stable form that would survive the rDNA hybridization steps. AFB1-modified nuclear DNA was therefore treated with alkali; hydroxide attacks at the C8 of guanine, breaking the C8-N9 bond and neutralizing the destabilizing positive charge generated on the N7-C N9 bonds (17, 26) . Two new adduct forms are produced. The quantitatively major adduct has been structurally identified as 2,3-dihydro-2-(N5-formyl-2',5',6'-triami- Fig. 2 illustrates the conversion of AFB1-N7-guanine to these two stable adduct forms. Chromatographic analysis was performed on glycine-treated and untreated DNA adducted in vitro to a level of 1,550 pmol of AFB1 per mg of DNA (14) . As shown in Fig. 2A , in vitro AFB,-adducted DNA contains predominantly AFB,-N7-guanine; after alkaline glycine treatment, AFB1-N7-guanine is quantitatively converted to AFB1-FAPyr and AFB,-Peak F (Fig. 2B ). Approximately 1.2% of the radioactivity as AFB1-N7-guanine remains unconverted and is thus lost. In addition, exposure of [3H]AFB1 to alkaline conditions causes loss of AFB1-bound tritium radioactivity. An average of 18% (14-24%) of the bound radioactivity was lost from nuclear DNA salmples during adduct stabilization under the alkaline glycine buffer conditions. Parallel studies in which DNA adducts with
[14C]AFB, were similarly treated indicated that, of the average 18% tritium loss; 6% was due to hydrolysis of the bound AFB1 moieties (either as bound AFB,-guanine adducts or as the aflatoxin moiety itself); the remaining 12% of tritium radioactivity loss was thus due to tritium exchange. Samples of nuclear DNA were taken before and after treatment to determine the amount of tritium radioactivity retaine'd in each sample set.
rDNA-rRNA Hybridization. The glycine-treated DNA isolates were incubated with rRNA to form rRNA-rDNA Rloop hybrids in formamide buffer as described by Wellauer and Dawid (21, 22) . R-loop hybrids are more dense than double-stranded DNA and can thus be separated from singleand double-stranded DNA in cesium chloride gradients, the extent of the shift in density being dependent upon the ratio of RNA to DNA within the hybrid molecules. ' Fig. 3A illus- trates the gradient profile of nuclear DNA, enriched in rDNA by one round of cesium salt centrifugation, hybridized with 18S and 28S' rRNA under these conditions. While rRNA-rDNA hybrids banded at a higher density than did tfie bulk of nuclear DNA, nonribosomal DNA was largely denatured and formed a broad band that obscured the rDNA hybrid peak. A fraction comprising 20-25% of each DNA gradient peak was collected and recentrifuged after adjustment of the solution density to 1.72 g/ml. Fig. 3B illustrates a typical gradient profile after the second centrifugation; here, the rDNA-rRNA hybrid was more completely separated from the broad peak of single-stranded DNA. Over the course of these two cesium salt density gradient steps, an average of 15% of the AFB1-bound tritium was lost from the rDNA fractions, and levels of bound AFB1 radioactivity measured in rDNA were corrected to reflect this loss. Yields of the rDNA fraction were 1.7-3.2 g from 25-30 mg of rat liver DNA.
Analysis of the Purified rDNA. The purity of the rDNA obtained from the radioactive peak of Fig. 3B was assessed by digesting the DNA isolate with EcoRI restriction endonuclease, separating the hydrolysates via electrophoresis on a 1% agarose gel, and comparing the digestion pattern with published restriction maps of the rRNA gene'region (Fig. 4A) as determined by Tantravahi and co-workers (27) . As shown in Fig. 4B , EcoRI digestion of the rRNA isolate produced a digestion pattern comparable to the previously reported rDNA restriction map. Three major'bands are seen with sizes of 11.4, 6.7, and 4.9 kb; each band is clear and distinct' with little ethidium bromide-staining DNA observable in the background of the gel.
To obtain higher sensitivty, electrophoretically separated EcoRI digests of rDNA were transferred to a nitrocellulose filter by the Southern method, and t1le filter was then hybridized with purified 32P-end-labeled 18S and 28S rRNA. As shown in Fig. 4C , the [32P]rRNA probes bound only to DNA in the principal ethiaium bromide-stain'ing bands. No other rRNA-hybrid bands were evident within the background.
AFB1 Adduction to Ribosomal Versus Nuclear DNA. We compared the levels of AFB1 adduction within rDNA versus total nuclear DNA, both isolated' from the liver tissue of AFBI-treated animals. 1, 200) in rDNA. AFB1 residues wore found to occur preferentially within rDNA at each dose level studied; on a pmol/mg basis, 4.2-to 4.6-fold more AFB1 residues were bound to rDNA than to nuclear DNA at thege doses. The increased guanine content characteristic of rDNA sequences could lead to a greater level of binding of carcinogens such as AFB1 that specifically modify guanine bases. High-pressure liquid chromatographic analysis of the base content of rDNA isolates showed them to be enriched by 25% in guanine compared to nuclear DNA (unpublished data). Thus the 4-to 5-fold greater adduction of rDNA versus nuclear DNA cannot be attributed simply to guanine enrichment. DISCUSSION We have established a dose-response relationship with respect to AFB1 adducts within rRNA genes isolated from the liver tissue of AFB1-treated animals. Further, the data pre- gen-DNA adduction and carcinogen-induced mutation. Knowledge of the mutagenic efficiency of-specific DNA adduct lesions would permit the construction of more accurate models relating structural DNA damage and altered gene expression. Bacterial assay systems have provided useful tools with which to approximate the mutagenic potency of carcinogen-DNA moieties. Stark and co-workers, measuring forward mutation to 8-azaguanine resistance in AFB,-treateq Salmonella typhimurium cultures, found approximately 20 AFB1-DNA adducts in the bacterial genome per observed mutation (11) , while Beranek and co-workers, measuring reverse mutation to histidine prototrophy in Salmonella, found approximately 6 aminofluorene DNA adducts in the bacterial genome per observed mutation (28) . Similar methods using reverse mutation assay systems in Salmonella have been (29) and arylamines (13) . These approaches have inherent limitations because they have not localized DNA modification within the specific gene loci at which mutation is simultaneously scored. Recent findings by Kaden and co-workers on the relationship between AFB1-induced mutation and AFB1-DNA adduction in hypermutable human lymphoblast cell lines provide some preliminary data with which to assess, in eukaryotic cells, the importance of gene hypermodification in calculations of the mutagenic efficiency of carcinogen adducts (30) . In these experiments, the efficiency of AFB1-DNA adducts giving rise to trifluorothymidine resistance, due to mutation within the thymidine kinase (TK) gene, was calculated to be about 20%. Assuming the maintenance of a transcribed chromatin conformation within the TK gene similar to the conformation found within rDNA, it can be postulated that a 4-to 5-fold increase in AFB1 modification of the TK gene sequences would be observed; thus the actual mutagenic efficiency of an AFB1 adduct in this hypermutable cell population could be as high as 1009o--i.e., one mutation produced, on average, for each AFB1 adduct within the TK gene sequence. An observed ratio of 1:1 between carcinogen modification and induced mutation within a specific gene target would have important implications in the interpretation of carcinogen and mutagen bioassay data on chemicals to which humans are exposed.
Left unresolved, however, in these and other mechanistic studies of AFB1-induced mutation is the identification of the specific premutagenic lesion(s) formed in AFB1-modified DNA. Spontaneous or enzymatic removal of the AFB1-N7-guanine adduct should give rise to apurinic sites at a high frequency. Loeb and co-workers have demonstrated that apurinic lesions in DNA result in mutations in defined prokaryotic systems (31) . The coexistence of apurinic sites together with stable AFB1-FAPyr adducts represent two types of potentially premutagenic lesions in the DNA of AFB1-treated cell populations. The possibility thus exists that multiple mechanisms may thus account for the mutagenic potency of N7-substituted alkylating agents such as AFB1.
Other parameters of chromatin composition and structure may also modulate the levels of chemical modification within mutable gene loci. Humayun and co-workers have adapted the Maxam-Gilbert procedure for DNA sequence analysis to probe the influence of flanking nucleotide sequences on AFB1-DNA modification (32, 33) . Within double-stranded DNAj identifiable guanine residues were found to be preferentially modified by AFB1 according to rules determined from a knowledge of vicinal nucleotide sequences. While the transcribed conformation of an expressed gene sequence may thus direct preferential modification of these DNA regions upon carcinogen exposure, the nucleotide composition and sequence within a gene may further influence the observed relationships between carcinogen-DNA interactions and biological end points such as mutation.
Our findings justify further refinement of this experimental strategy to define more accurately relationships between carcinogen-DNA modification and the changes in gene expression accompanying chemically induced mutagenesis and tumorigenesis. Preferential localization of carcinogen adducts within expressed gene sequences suggests that DNA perturbations of etiological importance to cell transformation and mutagenesis may also occur to a greater extent in expressed gene loci. It may be possible to refine the approaches outlined in this report to examine the chemical modification of DNA regions within mutational targets and to describe the underlying mechanisms mediating premuta-
